EUVIMEDEUVIMED entdecken
Open Access

Irritability in children with RASopathies, insights into emotional dysregulation and social impairment

Yaffa Serur, Naomi Fuhrmann, Odeya Russo, Tamar Green

European Child & Adolescent Psychiatry · 2025

DOI: 10.1007/s00787-025-02767-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Child & Adolescent Psychiatry, 2025. Verfasst von Yaffa Serur und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Interdisciplinary Brain Sciences, Department of Psychiatry and Behavioral Science, School of Medicine, Stanford University, 401 Quarry Ro…. Hauptthemen laut MEDLINE: Noonan Syndrome, Neurofibromatosis 1, Irritable Mood, Affective Symptoms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, National Institute of Child Health and Human Development, Postdoctoral Research Fellowship in Child & Adolescent Psychiatry supported by the Harvey L. and Maud C. Sorensen Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RASopathies, including Noonan Syndrome (NS) and Neurofibromatosis type 1 (NF1), are developmental disorders caused by germline mutations in genes of the RAS-mitogen-activated protein kinase pathway (RAS-MAPK). This study investigates irritability, a highly prevalent transdiagnostic construct, in children with NS and NF1 and the impact of RASopathy status on the associations between irritability, emotional dysregulation-related disorders, and social impairment. The sample comprises 174 children aged 4–17 (age mean = 9.49; 98 females), including 113 children with RASopathies (NS n = 85, NF1 n = 28) and 61 age-sex-matched typically developed (TD) children. We used parent proxy questionnaires (CBCL, SRS) to assess irritability, symptoms of ADHD, defiance, anxiety/depression, and social impairment while controlling for cognitive measures (IQ). Children with RASopathies exhibited higher irritability than TD children (mean difference = 1.09; p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Noonan SyndromeNeurofibromatosis 1Irritable MoodAffective SymptomsEmotional RegulationHumansFemaleChild, PreschoolMaleChildAdolescentAttention Deficit Disorder with Hyperactivity

Stichwörter der Autor:innen

Emotional dysregulation-related disordersIrritabilityNeurofibromatosis type 1Noonan syndromeRASopathiesSocial impairment

Autor:innen und Institutionen

  • Division of Interdisciplinary Brain Sciences, Department of Psychiatry and Behavioral Science, School of Medicine, Stanford University, 401 Quarry Road, Stanford, CA, 94305-5717, USA. yserur@stanford.edu.
  • Division of Interdisciplinary Brain Sciences, Department of Psychiatry and Behavioral Science, School of Medicine, Stanford University, 401 Quarry Road, Stanford, CA, 94305-5717, USA.

Förderung

  • NICHD NIH HHS
  • National Institute of Child Health and Human Development
  • Postdoctoral Research Fellowship in Child & Adolescent Psychiatry supported by the Harvey L. and Maud C. Sorensen Foundation
  • Stanford Maternal and Child Health Research Institute
  • Stephen Bechtel Endowed Faculty Scholar in Pediatric Translational Medicine
  • Neurofibromatosis Therapeutic Acceleration Program at the John Hopkins University School of Medicine

Zitieren

APA

Serur, Y., Fuhrmann, N., Russo, O., & Green, T. (2025). Irritability in children with RASopathies, insights into emotional dysregulation and social impairment. European Child & Adolescent Psychiatry. https://doi.org/10.1007/s00787-025-02767-w

Vancouver

Serur Y, Fuhrmann N, Russo O, Green T. Irritability in children with RASopathies, insights into emotional dysregulation and social impairment. European Child & Adolescent Psychiatry. 2025. doi:10.1007/s00787-025-02767-w

BibTeX
@article{Serur2025,
  author = {Serur, Yaffa and Fuhrmann, Naomi and Russo, Odeya and Green, Tamar},
  title = {Irritability in children with RASopathies, insights into emotional dysregulation and social impairment},
  journal = {European Child & Adolescent Psychiatry},
  year = {2025},
  doi = {10.1007/s00787-025-02767-w}
}
Kostenlos starten →